Apoptosis
Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
- Caspase(102)
- 14.3.3 Proteins(2)
- Apoptosis Inducers(45)
- Bax(7)
- Bcl-2 Family(122)
- Bcl-xL(8)
- c-RET(9)
- IAP(27)
- KEAP1-Nrf2(67)
- MDM2(15)
- p53(128)
- PC-PLC(5)
- PKD(8)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(151)
- Other Apoptosis(900)
- Apoptosis Detection
- Caspase Substrate
- APC(6)
- PD-1/PD-L1 interaction(91)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Pyroptosis(32)
Apoptosis 相关产品(2721)
- GC34181Tauroursodeoxycholate (TUDCA)CAS: 14605-22-2纯度: >98.00%
牛磺酸脱氧胆酸盐(TUDCA)是包括肝细胞在内的多种细胞的细胞保护剂,也是癌症细胞凋亡的诱导剂。
- GC34214Adalimumab (Anti-Human TNF-alpha, Human Antibody)CAS: 331731-18-1纯度: >99.50%
阿达木单抗(抗人 TNF-α,人抗体)是治疗类风湿性关节炎的主要疗法之一。
- GC34218Nivolumab (BMS-936558)CAS: 946414-94-4纯度: >98.50%
Nivolumab 是一种抗癌单克隆抗体,是一种程序性死亡受体-1 阻断人 IgG4 抗体,用于治疗晚期(转移性)非小细胞肺癌。
- GC34579EtanerceptCAS: 185243-69-0纯度: >95.00% / >98.00%
Etanercept是一种竞争性肿瘤坏死因子(TNF)抑制剂,抑制TNF-α和TNF-β与细胞表面受体的结合。
- GC34634JG-98CAS: 1456551-16-8纯度: >98.00%
JG-98 is an allosteric inhibitor of Hsp70 that binds tightly to a deep pocket that is conserved in members of the Hsp70 family. JG-98 induces classical apoptosis features, including morphological changes consistent with programmed cell death and positive annexin staining. JG-98 exhibits anticancer activity.
- GC34642KI696 isomerCAS: 1799974-69-8纯度: >99.00%
KI696isomer是KI696的低活性异构体。KI696是一种高亲和力探针,可破坏Keap1/NRF2相互作用。
- GC34831Tauroursodeoxycholate dihydrateCAS: 117609-50-4纯度: >98.00%
Tauroursodeoxycholatedihydrate(TUDCAdihydrate;UR906dihydrate;Taurolitedihydrate)是一种内质网应激抑制剂。Tauroursodeoxycholate显著降低凋亡分子如caspase-3和caspase-12表达。Tauroursodeoxycholate也抑制ERK。
- GC34965(20S)-ProtopanaxatriolCAS: 34080-08-5纯度: >98.00%
(20S)-Protopanaxatriol是一种来源于人参皂苷的代谢产物,具有多种生物活性和药理作用。
- GC34980(E)-Ferulic acidCAS: 537-98-4纯度: >99.00%
Trans-ferulic acid is a potent activator of AMPKunder high glucose condition.
- GC35001(S)-Gossypol acetic acidCAS: 1189561-66-7纯度: >99.00%
(S)-Gossypol acetic acid 是天然产物 Gossypol 的异构体。(S)-Gossypol 以高亲和力结合到 Bcl-xL 和 Bcl-2 蛋白的 BH3 结合沟。
- GC35013[8]-ShogaolCAS: 36700-45-5纯度: >99.50%
[8]-Shogaol,生姜中的一种刺激性酚类化合物,具有抗血小板活性 (IC50=5 μM) 和抑制 COX-2 (IC50=17.5 μM)。[8]-Shogaol 诱导人白血病细胞凋亡。
- GC3505714-DeoxyandrographolideCAS: 4176-97-0纯度: >98.00%
A diterpene lactone with diverse biological properties
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC34181 | Tauroursodeoxycholate (TUDCA) | 14605-22-2 | >98.00% | |
牛磺酸脱氧胆酸盐(TUDCA)是包括肝细胞在内的多种细胞的细胞保护剂,也是癌症细胞凋亡的诱导剂。 | ||||
| GC34214 | Adalimumab (Anti-Human TNF-alpha, Human Antibody) | 331731-18-1 | >99.50% | |
阿达木单抗(抗人 TNF-α,人抗体)是治疗类风湿性关节炎的主要疗法之一。 | ||||
| GC34218 | Nivolumab (BMS-936558) | 946414-94-4 | >98.50% | |
Nivolumab 是一种抗癌单克隆抗体,是一种程序性死亡受体-1 阻断人 IgG4 抗体,用于治疗晚期(转移性)非小细胞肺癌。 | ||||
| GC34263 | Bak BH3 | - | - | |
BakBH3是一种多肽,源于Bak蛋白的BH3结构域,在细胞中,能够抑制Bcl-xL的活性。 | ||||
| GC34303 | Taltobulin hydrochloride (HTI-286 hydrochloride) | - | - | |
An inhibitor of microtubule polymerization | ||||
| GC34389 | PUMA BH3 | - | - | |
PUMABH3是一种p53正向凋亡调控因子(PUMA)BH3结构域多肽,作为Bak的直接激活剂,Kd值为26nM。 | ||||
| GC34511 | BTR-1 | 18331-34-5 | >99.50% | |
BTR-1 induces cytotoxicity in a time- and concentration-dependent manner on leukemia cell line CEM. BTR-1 affects DNA replication by inducing a block at S phase and leads to activation of apoptosis to induce cell death. | ||||
| GC34513 | C25-140 | 1358099-18-9 | >98.00% | |
C25-140是一种能够抑制TRAF6-Ubc13相互作用的小分子化合物,能够直接与E3连接酶TNF受体相关因子6(TRAF6)结合,从而阻断TRAF6与Ubc13的相互作用,并因此降低TRAF6的活性。 | ||||
| GC34543 | cRIPGBM | 2361988-76-1 | - | |
cRIPGBM是RIPGBM的促凋亡衍生物,是通过与受体相互作用蛋白激酶2(RIPK2)结合,诱导GBM肿瘤干细胞凋亡的选择性诱导剂,对GBM-1细胞的EC50值为68nM。 | ||||
| GC34579 | Etanercept | 185243-69-0 | >95.00% / >98.00% | |
Etanercept是一种竞争性肿瘤坏死因子(TNF)抑制剂,抑制TNF-α和TNF-β与细胞表面受体的结合。 | ||||
| GC34605 | GSK840 | 2361146-30-5 | >99.00% | |
GSK840(GSK’840)是一种受体相互作用蛋白激酶3(RIP3orRIPK3)抑制剂,高亲和力结合RIP3激酶结构域,IC50值为0.9nM,并抑制激酶活性,IC50值为0.3nM。 | ||||
| GC34606 | GSK-843 | 1601496-05-2 | >98.00% | |
GSK-843是一种受体相互作用蛋白激酶3(RIP3orRIPK3)抑制剂,高亲和力结合RIP3激酶结构域,IC50值为8.6nM,并抑制激酶活性,IC50值为6.5nM。 | ||||
| GC34634 | JG-98 | 1456551-16-8 | >98.00% | |
JG-98 is an allosteric inhibitor of Hsp70 that binds tightly to a deep pocket that is conserved in members of the Hsp70 family. JG-98 induces classical apoptosis features, including morphological changes consistent with programmed cell death and positive annexin staining. JG-98 exhibits anticancer activity. | ||||
| GC34642 | KI696 isomer | 1799974-69-8 | >99.00% | |
KI696isomer是KI696的低活性异构体。KI696是一种高亲和力探针,可破坏Keap1/NRF2相互作用。 | ||||
| GC34831 | Tauroursodeoxycholate dihydrate | 117609-50-4 | >98.00% | |
Tauroursodeoxycholatedihydrate(TUDCAdihydrate;UR906dihydrate;Taurolitedihydrate)是一种内质网应激抑制剂。Tauroursodeoxycholate显著降低凋亡分子如caspase-3和caspase-12表达。Tauroursodeoxycholate也抑制ERK。 | ||||
| GC34862 | WYC-209 | 2131803-90-0 | >99.50% | |
WYC-209是一种合成类视黄醇,能抑制恶性小鼠黑色素瘤肿瘤再生细胞(TRC)的增殖,IC50值为0.19μM。WYC-209主要细胞靶点是维甲酸受体(RARs)。 | ||||
| GC34928 | PD-1-IN-17 | 1673560-66-1 | - | |
An inhibitor of PD-1 signaling | ||||
| GC34929 | PD-1-IN-17 TFA | - | - | |
An inhibitor of PD-1 signaling | ||||
| GC34965 | (20S)-Protopanaxatriol | 34080-08-5 | >98.00% | |
(20S)-Protopanaxatriol是一种来源于人参皂苷的代谢产物,具有多种生物活性和药理作用。 | ||||
| GC34980 | (E)-Ferulic acid | 537-98-4 | >99.00% | |
Trans-ferulic acid is a potent activator of AMPKunder high glucose condition. | ||||
| GC34981 | (E)-Flavokawain A | 37951-13-6 | >99.00% | |
A chalcone with diverse biological activities | ||||
| GC35001 | (S)-Gossypol acetic acid | 1189561-66-7 | >99.00% | |
(S)-Gossypol acetic acid 是天然产物 Gossypol 的异构体。(S)-Gossypol 以高亲和力结合到 Bcl-xL 和 Bcl-2 蛋白的 BH3 结合沟。 | ||||
| GC35013 | [8]-Shogaol | 36700-45-5 | >99.50% | |
[8]-Shogaol,生姜中的一种刺激性酚类化合物,具有抗血小板活性 (IC50=5 μM) 和抑制 COX-2 (IC50=17.5 μM)。[8]-Shogaol 诱导人白血病细胞凋亡。 | ||||
| GC35057 | 14-Deoxyandrographolide | 4176-97-0 | >98.00% | |
A diterpene lactone with diverse biological properties | ||||
